Characterization of a novel phosphodiesterase type 5 inhibitor: JNJ-10258859.
Qiu Y, Bhattacharjee S, Kraft P, John TM, Craig E, Haynes-Johnson D, Guan J, Jiang W, Macielag M, Sui Z, Clancy J, Lundeen S.
Qiu Y, et al.
Eur J Pharmacol. 2003 Jul 4;472(1-2):73-80. doi: 10.1016/s0014-2999(03)01868-5.
Eur J Pharmacol. 2003.
PMID: 12860475